Somatostatin Receptor Avidity in Gastrointestinal Stromal Tumors: Theranostic Implications of Gallium-68 Scan and Eligibility for Peptide Receptor Radionuclide Therapy

This manuscript reports on a patient with a metastatic gastrointestinal stromal tumor (GIST) refractory to standard first-line treatment, who underwent a gallium-68 scan based on pre-clinical data of somatostatin receptor (SSTR) expression in such tumors. The gallium-68 DOTATATE scan determined sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Loaiza-Bonilla, Arturo, Bonilla-Reyes, Paula A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703593/
https://www.ncbi.nlm.nih.gov/pubmed/29188154
http://dx.doi.org/10.7759/cureus.1710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703593/
https://www.ncbi.nlm.nih.gov/pubmed/29188154
http://dx.doi.org/10.7759/cureus.1710

Ejemplares similares